scholarly journals Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice

2015 ◽  
Vol 17 (1) ◽  
Author(s):  
Julie Decock ◽  
Wouter Hendrickx ◽  
Sally Thirkettle ◽  
Ana Gutiérrez-Fernández ◽  
Stephen D Robinson ◽  
...  
Oncogene ◽  
2003 ◽  
Vol 22 (30) ◽  
pp. 4664-4674 ◽  
Author(s):  
Teresa A Rose-Hellekant ◽  
Lisa M Arendt ◽  
Matthew D Schroeder ◽  
Kennedy Gilchrist ◽  
Eric P Sandgren ◽  
...  

2008 ◽  
Vol 99 (02) ◽  
pp. 290-294 ◽  
Author(s):  
Valerie Christiaens ◽  
Ilse Scroyen ◽  
H. Roger Lijnen

SummaryObesity is a common disorder, and related diseases such as diabetes, atherosclerosis, hypertension, cardiovascular disease and cancer are a major cause of mortality and morbidity inWesterntype societies. Development of obesity is associated with extensive modifications in adipose tissue involving adipogenesis, angiogenesis and extracellular matrix proteolysis. The fibrinolytic (plasminogen/plasmin) and matrix metalloproteinase (MMP) systems cooperate in these processes. A nutritionally induced obesity model in transgenic mice has been used extensively to study the role of the fibrinolytic and MMP systems in the development of obesity. These studies support a role of both systems in adipogenesis and obesity, and suggest that modulation of proteolytic activity may affect development of adipose tissue.


2020 ◽  
Vol 40 (8) ◽  
Author(s):  
Xin Li ◽  
Yueshui Zhao ◽  
Chuan Chen ◽  
Li Yang ◽  
Hyun-ho Lee ◽  
...  

ABSTRACT Fibrosis is recognized as the major pathological change in adipose tissue during the development of obesity. However, the detailed mechanisms governing the interactions between the fibrotic components and their modifiers remain largely unclear. Here, we reported that matrix metalloproteinase 14 (MMP14), a key pericellular collagenase, is dramatically upregulated in obese adipose tissue. We generated a doxycycline-inducible adipose tissue-specific MMP14 overexpression model to study its regulatory function. We found that overexpression of MMP14 in the established obese adipose tissue leads to enlarged adipocytes and increased body weights in transgenic mice. Furthermore, the mice exhibited decreased energy expenditure, impaired lipid metabolism, and insulin resistance. Mechanistically, we found that MMP14 digests collagen 6α3 to produce endotrophin, a potent costimulator of fibrosis and inflammation. Unexpectedly, when overexpressing MMP14 in the early-stage obese adipose tissue, the transgenic mice showed a healthier metabolic profile, including ameliorated fibrosis and inflammation, as well as improved lipid and glucose metabolism. This unique metabolic phenotype is likely due to digestion/modification of the dense adipose tissue extracellular matrix by MMP14, thereby releasing the mechanical stress to allow for its healthy expansion. Understanding these dichotomous impacts of MMP14 provides novel insights into strategies to treat obesity-related metabolic disorders.


2015 ◽  
Vol 14 (12) ◽  
pp. 3234-3246 ◽  
Author(s):  
Pascal Schlage ◽  
Tobias Kockmann ◽  
Fabio Sabino ◽  
Jayachandran N. Kizhakkedathu ◽  
Ulrich auf dem Keller

2007 ◽  
Vol 292 (4) ◽  
pp. H1847-H1860 ◽  
Author(s):  
Marina R. Bergman ◽  
John R. Teerlink ◽  
Rajeev Mahimkar ◽  
Luyi Li ◽  
Bo-Qing Zhu ◽  
...  

Although enhanced cardiac matrix metalloproteinase (MMP)-2 synthesis has been associated with ventricular remodeling and failure, whether MMP-2 expression is a direct mediator of this process is unknown. We generated transgenic mice expressing active MMP-2 driven by the α-myosin heavy chain promoter. At 4 mo MMP-2 transgenic hearts demonstrated expression of the MMP-2 transgene, myocyte hypertrophy, breakdown of Z-band registration, lysis of myofilaments, disruption of sarcomere and mitochondrial architecture, and cardiac fibroblast proliferation. Hearts from 8-mo-old transgenic mice displayed extensive myocyte disorganization and dropout with replacement fibrosis and perivascular fibrosis. Older transgenic mice also exhibited a massive increase in cardiac MMP-2 expression, representing recruitment of endogenous MMP-2 synthesis, with associated expression of MMP-9 and membrane type 1 MMP. Increases in diastolic [control (C) 33 ± 3 vs. MMP 51 ± 12 μl; P = 0.003] and systolic (C 7 ± 2 vs. MMP 28 ± 14 μl; P = 0.003) left ventricular (LV) volumes and relatively preserved stroke volume (C 26 ± 4 vs. MMP 23 ± 3 μl; P = 0.16) resulted in markedly decreased LV ejection fraction (C 78 ± 7% vs. MMP 48 ± 16%; P = 0.0006). Markedly impaired systolic function in the MMP transgenic mice was demonstrated in the reduced preload-adjusted maximal power (C 240 ± 84 vs. MMP 78 ± 49 mW/μl2; P = 0.0003) and decreased end-systolic pressure-volume relation (C 7.5 ± 1.5 vs. MMP 4.7 ± 2.0; P = 0.016). Expression of active MMP-2 is sufficient to induce severe ventricular remodeling and systolic dysfunction in the absence of superimposed injury.


2006 ◽  
Vol 15 (1) ◽  
pp. 35-42 ◽  
Author(s):  
Baki Akgul ◽  
Regina Pfefferle ◽  
Gian Paolo Marcuzzi ◽  
Paola Zigrino ◽  
Thomas Krieg ◽  
...  

2013 ◽  
Vol 8 (4) ◽  
pp. 350-360 ◽  
Author(s):  
Laura Conti ◽  
Stefania Lanzardo ◽  
Manuela Iezzi ◽  
Monica Montone ◽  
Elisabetta Bolli ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document